AZD8601 study in CABG patients

Trial Identifier: D9150C00003
Sponsor: AstraZeneca
NCTID:: NCT03370887
Start Date: February 2018
Primary Completion Date: June 2021
Study Completion Date: June 2021
Condition: Congestive Heart Failure

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English Version
Finnish Translation
German Translation

Trial Locations

Country Location
DE M�nchen, DE, 81675
DE M�nchen, DE, 80363
FI Kuopio, FI, 70210
FI Tampere, FI, 33520
FI Turku, FI, 20520
NL Amsterdam, NL, 1081 HV
NL Groningen, NL, 9713 GZ
SE G�teborg, SE, 413 45
SE Uppsala, SE, 751 85
US, CT New Haven, CT, US, 06510